Trial
NCT05695378
Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Kainos Medicine Inc.
Collaborators
Parexel
Condition
Multiple System Atrophy
Intervention
KM-819
Why stopped
Sponsor has decided to withdraw the study due to safety issue and re-initiate with a new clinical study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19